🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

Recruitingn/aAges 18 Years - anyAllGCS Ramsay Santé pour l'Enseignement et la Recher…
NCT05586867 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult dialysis patient * Patient able to understand the information necessary for the study and having signed his written consent to participate * Affiliated patient or beneficiary of a social security scheme. Exclusion Criteria: * Medically unstable or frail patient * Patient with hemoglobin less than 7g/dl * Patient with HIV+ or AIDS, patient with replicating hepatitis B or C * Patient participating in another clinical study requiring an additional blood sample * Patient benefiting from legal protection measures (guardianship, guardianship, etc.) adult under guardianship, guardianship or other legal protection, deprived of freedom by judicial or administrative decision * Pregnant, breastfeeding or parturient woman
💊

What it tests

  • Blood test
📍

Where

1 site
Hôpital Privé Claude Galien
Quincy-sous-Sénart, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy